• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
WANG Chen, GUO Wei, WANG Xin, YU Dongmei, WANG Yuheng, YAO Wenbing. Condition of human Th17 cell differentiation induced in vitro[J]. Journal of China Pharmaceutical University, 2016, 47(1): 106-111. DOI: 10.11665/j.issn.1000-5048.20160116
Citation: WANG Chen, GUO Wei, WANG Xin, YU Dongmei, WANG Yuheng, YAO Wenbing. Condition of human Th17 cell differentiation induced in vitro[J]. Journal of China Pharmaceutical University, 2016, 47(1): 106-111. DOI: 10.11665/j.issn.1000-5048.20160116

Condition of human Th17 cell differentiation induced in vitro

More Information
  • In this study, a series of related indicators were investigated via flow cytometry, enzyme-linked immuno-sorbent assay(ELISA)and quantitative real-time PCR(Q-PCR)technology to assess the in vitro differentiation of human Th17 cells. Human peripheral blood mononuclear cells(PBMCs)were purified from fresh human blood using gradient centrifugation and the Th17 cells were then induced with different cytokines(IL-1β, IL-6, TGF-β and IL-23)at different induction times(1, 2, 3, 4 d)to compare the effects on Th17 cell differentiation under these conditions. Data showed that IL-1β, IL-6, TGF-β or IL-23 alone play a promoting role in Th17 cell differentiation and combination of IL-1β, IL-6, TGF-β and IL-23 could induce efficient human Th17 cell differentiation in vitro to achieve the best. Further optimization of the induction time found that the Th17 cell differentiation efficiency gradually increased with the extension of the time; however, when culturing for 3 d, it reached the peak number and then decreased in spite of the time increase. Finally the optimal condition of in vitro polarization of human Th17 cells was established, in which the purified PBMCs were cultured with anti-CD3 and anti-CD28 as the basal conditions, and co-cultured with IL-1β, IL-6, TGF-β and IL-23 for 3 d to effectively induce the differentiation of Th17 cells. The inducing efficiency is significantly higher than that in normal control. At the optimal condition, Th17 cell differentiation frequency(CD4+IL-17A+)was found to increase to nearly 10% through flow cytometry analysis and the secretion level of IL-17A in cell supernatants was also detected to reach 3 ng/mL using ELISA methods. In addition, gene expression of IL-17A was determined by quantitative real-time PCR using pre-designed primers by the comparative method of relative quantitation(ΔΔCt)and β-actin gene was used as an internal control for sample normalization. The results showed that the expression of IL-17A mRNA could be increased about 15 times co-culturing with IL-1β, IL-6, TGF-β and IL-23 for 3 d. The protocol of efficient human Th17 cell differentiation presented in this paper is simple, rapid and easy to be repeated. This study provides an effective detection platform for the research of Th17 cell function and development of related drugs targeting Th17 cells for autoimmune disease treatment.
  • [1]
    Cua DJ,Sherlock J,Chen Y,et al.Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain[J].Nature,2003,421(6924):744-748.
    [2]
    Singh RP,Hasan S,Sharma S,et al.Th17 cells in inflammation and autoimmunity[J].Autoimmun Rev,2014,13(12):1174-1181.
    [3]
    Vadasz Z,Rimar D,Toubi E.The new era of biological treatments[J].Isr Med Assoc J,2014,16(12):793-798.
    [4]
    Yang J, Sundrud MS, Skepner J, et al. Targeting Th17 cells in autoimmune diseases[J].Trends Pharmacol Sci,2014,35(10):493-500.
    [5]
    Wei G,Wang C,Luo C,et al.Study on mice Th17 cell differentiation induced in vitro[J].Pharm Biotechnol(药物生物技术),2013,20(6):514-517.
    [6]
    Bedoya SK, Lam B, Lau K, et al. Th17 cells in immunity and autoimmunity[J].Clin Dev Immunol,2013,2013:986789.
    [7]
    Chung Y,Chang SH,Martinez GJ,et al.Critical regulation of early Th17 cell differentiation by interleukin-1 signaling[J].Immunity,2009,30(4):576-587.
    [8]
    Guo L,Wei G,Zhu J,et al.IL-1 family members and STAT activators induce cytokine production by Th2,Th17,and Th1 cells[J].Proc Natl Acad Sci U S A,2009,106(32):13463-13468.
    [9]
    Weaver CT,Harrington LE,Mangan PR,et al.Th17:an effector CD4 T cell lineage with regulatory T cell ties[J].Immunity,2006,24(6):677-688.
    [10]
    Maddur MS,Miossec P,Kaveri SV,et al.Th17 cells:biology,pathogenesis of autoimmune and inflammatory diseases,and therapeutic strategies[J].Am J Pathol,2012,181(1):8-18.
    [11]
    Ikeda S, Saijo S, Murayama MA, et al. Excess IL-1 signaling enhances the development of Th17 cells by downregulating TGF-beta-induced Foxp3 expression[J].J Immunol,2014,192(4):1449-1458.
    [12]
    Ghoreschi K,Laurence A,Yang XP,et al.Generation of pathogenic TH17 cells in the absence of TGF-beta signalling[J].Nature,2010,467(7318):967-971.
    [13]
    Peters A,Lee Y,Kuchroo VK.The many faces of Th17 cells[J].Curr Opin Immunol,2011,23(6):702-706.
    [14]
    Gutcher I,Donkor MK,Ma Q,et al.Autocrine transforming growth factor-beta1 promotes in vivo Th17 cell differentiation[J].Immunity,2011,34:396-408.
    [15]
    Croxford AL,Kulig P,Becher B.IL-12-and IL-23 in health and disease[J].Cytokine Growth Factor Rev,2014,25(4):415-421.
  • Related Articles

    [1]ZHANG Ruiqing, YANG Wenqian, YU Yubing, TU Jiasheng, SUN Yixin. Pharmacokinetics of nifedipine matrix sustained-release pellets in rats and the relationship with CYP3A4[J]. Journal of China Pharmaceutical University, 2018, 49(4): 427-432. DOI: 10.11665/j.issn.1000-5048.20180407
    [2]LIANG Yan, XING Rong, LIU Jiali, MAO Yong, FU Hanxu, XIE Lin, WANG Guangji. Advances of novel technologies and theories in pharmacokinetic research[J]. Journal of China Pharmaceutical University, 2014, 45(6): 607-616. DOI: 10.11665/j.issn.1000-5048.20140601
    [3]CHEN Ling-ping, L Wen-li, PING Qi-neng. Preparation and bioavailability of bupropion hydrochloride sustained-release pellets[J]. Journal of China Pharmaceutical University, 2009, 40(5): 421-425.
    [4]DENG Yan-ping, XIAO Yan-yu, PING Qi-neng, GU Xiao-zhen, BAO Quan-ying. Combined system of sinomenine hydrochloride sustained-release pellets[J]. Journal of China Pharmaceutical University, 2009, 40(3): 222-226.
    [5]Pharmacokinetic Study on the Sustained-release Tablets of Labetalol in Dogs[J]. Journal of China Pharmaceutical University, 2003, (6): 48-52.
    [6]Studies on Pharmacokinetics and Bioeqivalence of Aspirin Sustained-Release Pellets[J]. Journal of China Pharmaceutical University, 1993, (6): 334-337.
    [7]Pharmacokinetics and Pharmacodynamics of Sophocarpine and Oxysophocarpine[J]. Journal of China Pharmaceutical University, 1992, (3): 161-164.
    [8]Development of Enteric Aspirin Pellets[J]. Journal of China Pharmaceutical University, 1990, (3): 147-150.
    [9]DEVELOPMENT AND PHARMACOKINETIC STUDY OF SUSTAINED RELEASE IBUPROFEN PELLETS[J]. Journal of China Pharmaceutical University, 1989, (5): 266-270.
    [10]PHARMACOKINETICS OF MATRINR IN RABBITS[J]. Journal of China Pharmaceutical University, 1986, (4): 309-311.

Catalog

    Article views (1290) PDF downloads (3387) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return